Pharmacoepidemiology, as an interdisciplinary domain amalgamating pharmacology and epidemiology, is dedicated to scrutinizing the real-world ramifications of pharmaceuticals within populations. Employing observational research methodologies and scrutinizing extensive datasets, pharmacoepidemiologists discern intricate patterns concerning drug employment, adverse effects, and therapeutic consequences. A pivotal objective is the provision of evidence-based insights tailored for healthcare practitioners, policymakers, and the pharmaceutical sector. This, in turn, shapes decisions regarding drug prescription practices, regulatory measures, and public health strategies. Pharmacoepidemiological inquiries incorporate diverse study designs, encompassing cohort studies and case-control analyses, to meticulously explore outcomes related to drug usage.
The field continually evolves to surmount challenges inherent in addressing confounding variables and biases during the phases of data collection, analysis, and interpretation. The accrued insights play a pivotal role in the continual refinement of clinical guidelines and the vigilance inherent in drug safety monitoring protocols.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary